Daniel Skovronsky
SVP, CSO, and Pres. LRL, Eli Lilly and Company.
Companies
- IlluminaBoard member Jun 23, 2026 to now1
- Myriad GeneticsBoard member Jul 23, 2020 to now2
- Eli Lilly and CompanySVP, CSO, and Pres. LRL Jun 11, 2018 to now3
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY162,782 shares4$207.2M at $1,272.75Feb 11, 2026
Myriad Genetics MYGN195,507 shares5$812.3K at $4.16Jun 23, 2026
Illumina ILMN1,674 shares6$439.5K at $262.52Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 1,674 shares at $164.28 of Illumina6
- Jun 4, 2026Granted 59,701 shares of Myriad Genetics7
- Feb 9, 2026Granted 15,548 shares at $1,044.67 of Eli Lilly and Company4
- Feb 1, 2026Shares withheld for tax 5,641 shares at $1,037.15 of Eli Lilly and Company8
- Feb 1, 2026Exercised options 12,684 shares of Eli Lilly and Company8
- Nov 10, 2025Gift 179 shares of Eli Lilly and Company9
- Aug 12, 2025Bought 1,000 shares at $634.40 of Eli Lilly and Company10
- Jun 5, 2025Granted 49,796 shares of Myriad Genetics11
- Feb 10, 2025Granted 18,772 shares at $868.88 of Eli Lilly and Company12
- Feb 10, 2025Sold 710 shares at $865.76 of Eli Lilly and Company12
- Feb 10, 2025Sold 340 shares at $863.97 of Eli Lilly and Company12
- Feb 10, 2025Sold 3,950 shares at $862.69 of Eli Lilly and Company12
- Feb 1, 2025Shares withheld for tax 4,004 shares at $811.08 of Eli Lilly and Company13
- Feb 1, 2025Exercised options 8,989 shares of Eli Lilly and Company13
- Sep 11, 2024Gift 5,724 shares of Eli Lilly and Company14
- Sep 10, 2024Gift 111 shares of Eli Lilly and Company14
- Jun 6, 2024Granted 15,695 shares of Myriad Genetics15
- Feb 12, 2024Granted 12,910 shares at $737.26 of Eli Lilly and Company16
- Feb 1, 2024Shares withheld for tax 4,434 shares at $645.61 of Eli Lilly and Company17
- Feb 1, 2024Exercised options 9,941 shares of Eli Lilly and Company17
- Nov 10, 2023Gift 17 shares of Eli Lilly and Company18
- Aug 10, 2023Gift 249 shares of Eli Lilly and Company19
- Jun 1, 2023Granted 15,151 shares of Myriad Genetics20
- Feb 10, 2023Granted 18,388 shares at $345.12 of Eli Lilly and Company21
- Feb 1, 2023Shares withheld for tax 7,035 shares at $344.15 of Eli Lilly and Company22
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Aug 12, 2025 | LLY | Buy | $634.4K | +95.7% | +75.7% | +70.6% |
| Feb 10, 2025 | LLY | Sale | $4.3M | +44.0% | −16.4% | −3.5% |
| Oct 25, 2019 | LLY | Buy | $543.0K | +1035.8% | +879.9% | +16.1% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIllumina, Board member
- 2SEC EDGARMyriad Genetics, Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 5, 2026
- 8SEC EDGARForm 4 filed Feb 3, 2026
- 9SEC EDGARForm 4 filed Nov 10, 2025
- 10SEC EDGARForm 4 filed Aug 12, 2025
- 11SEC EDGARForm 4 filed Jun 6, 2025
- 12SEC EDGARForm 4 filed Feb 12, 2025
- 13SEC EDGARForm 4 filed Feb 4, 2025
- 14SEC EDGARForm 4 filed Sep 12, 2024
- 15SEC EDGARForm 4 filed Jun 10, 2024
- 16SEC EDGARForm 4 filed Feb 14, 2024
- 17SEC EDGARForm 4 filed Feb 2, 2024
- 18SEC EDGARForm 4 filed Nov 13, 2023
- 19SEC EDGARForm 4 filed Aug 11, 2023
- 20SEC EDGARForm 4 filed Jun 2, 2023
- 21SEC EDGARForm 4 filed Feb 14, 2023
- 22SEC EDGARForm 4 filed Feb 3, 2023